[Analysis of the efficacy and safety profile of sofosbuvir/velpatasvir/voxilaprevir in the treatment of patients with chronic hepatitis C with failed DAAs therapy]. [PDF]
Zhonghua Gan Zang Bing Za ZhiGuo Y +12 more
europepmc +1 more source
[Analysis of the factors influencing the elimination strategies with the current status of diagnosis and treatment of hepatitis C in hospital]. [PDF]
Zhonghua Gan Zang Bing Za Zhi, 2021 He N +7 more
europepmc +1 more source
Zhongshan Daxue xuebao. Yixue kexue ban, 2013 【目的】 探讨慢性丙型肝炎(CHC)与糖尿病(DM)的关系及其相关因素?【方法】 对200例CHC并DM患者(CHC+DM组)与242例CHC不合并DM患者(CHC组)的谷丙转氨酶(ALT)?谷草转氨酶(AST)?γ-谷氨酰转肽酶(GGT)?总胆红素(TB)?空腹血糖?空腹胰岛素?血甘油三酯及血清丙型肝炎病毒(HCV)RNA等相关指标进行检测?分析,比较两组之间各指标的差异,并将CHC+DM组分为携带者?轻度?中度?重度及不同年龄段进行对照比较,探讨CHC易发生DM的相关因素?【结果】 ①CHC ...
doaj
[Occurrence and recurrence of hepatitis C-related hepatocellular carcinoma after direct antiviral treatment]. [PDF]
Zhonghua Gan Zang Bing Za Zhi, 2022 Yang YQ, Xu XY.
europepmc +1 more source
[Research progress of direct-acting antiviral drugs in the treatment of chronic hepatitis C-related cirrhosis]. [PDF]
Zhonghua Gan Zang Bing Za ZhiZhao YF, Xu L, Mi YQ.
europepmc +1 more source
[Elimination of hepatitis C, our progress, challenges and hopes]. [PDF]
Zhonghua Gan Zang Bing Za Zhi, 2020 Rao HY, Li MY, Wei L.
europepmc +1 more source
Zhongshan Daxue xuebao. Yixue kexue ban, 1993 以台湾株丙型肝炎病毒的非结构区基因序列（HCV-T3）设计内外五条呈巢式排列的引物,结合AGPC核酸一步抽提法,寡聚核苷酸探针5′末端标记法和Southern电泳转移杂交法,建立简捷特异检测HCV-RNA的逆转录一多聚酶链反应（RT-PCR）技术。应用这一技术对121例非甲非乙型肝炎患者和45例抗HCV阳性的慢性乙型肝炎患者进行了血浆HCV-RNA检测,结果阳性率分别为66.1％（80/121）和66.7％（30/45）。本文对这一技术的方法学、HCV-RNA与抗HCV的关系 ...
doaj
[Progress, challenges and countermeasures of global hepatitis C elimination]. [PDF]
Zhonghua Gan Zang Bing Za Zhi, 2020 Chen ZD.
europepmc +1 more source
[Progress in clinical research related to viral hepatitis in 2025]. [PDF]
Zhonghua Gan Zang Bing Za ZhiDing Y, Li Y, Dou XG.
europepmc +1 more source
[Research progress on the quercetin target role and signaling pathway in anti-liver fibrosis]. [PDF]
Zhonghua Gan Zang Bing Za ZhiZhao RQ +9 more
europepmc +1 more source